Enter global pharmaceutical giants. US-based Eli Lilly and Novo Nordisk have both launched GLP-1-based treatments in India in ...

In this Newshour Special Edition, Navika Kumar speaks to India’s top endocrinologist Dr Ambrish Mithal on the country’s ...

Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

Group Captain Shubhanshu Shukla has become the first Indian to reach the International Space Station (ISS) on the Axiom-4 ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

A cyberattack on Synnovis has been linked to a patient's death at King's College Hospital, marking a serious hacking ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

The quest for weight loss has taken a dramatic turn. A wave of new-age solutions, from once-weekly injectables like Wegovy ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...